Application 761202

Type
BLA
Sponsor
SAMSUNG BIOEPIS CO LTD

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761202Byoovizranibizumab-nuna351(k) InterchangeableRx2026-08-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BYOOVIZRANIBIZUMAB-NUNAINJECTABLE;INJECTION0.5MG(10MG/ML)NoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ByoovizRANIBIZUMAB-NUNABIOGEN INC.e46db299-edd1-4457-89b2-c1e2e505f1b02025-12-01Warnings, Adverse reactionsExact identifier
application number: BLA761202
ndc (product): 64406-019
ByoovizRANIBIZUMAB-NUNAHarrow Eye, LLC77b53b2c-da0e-44b2-ade4-b08ff75a75842025-11-26Warnings, Adverse reactionsExact identifier
application number: BLA761202

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 3 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
64406-019Byoovizranibizumab-nunaBIOGEN INC.BLACurrent
64406-019ByoovizranibizumabBIOGEN INC.BLACurrent
64406-019Byoovizranibizumab-nunaBIOGEN INC.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85613SUPPL 2026-03-31
85607SUPPL 2026-03-31
84158SUPPL 2025-11-13
84147SUPPL 2025-11-13
83121SUPPL 2025-08-18
83115SUPPL 2025-08-18
75676SUPPL 2023-10-05
75673SUPPL 2023-10-05
74565SUPPL 2023-06-21
74555SUPPL 2023-06-20
71812SUPPL2022-08-16
71288SUPPL2022-06-13
71262SUPPL2022-06-10
68828ORIG2021-10-01
68692ORIG2021-09-21
68669ORIG2021-09-20